Can Corlanor (ivabradine) cause hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025 • View editorial policy

From the Guidelines

Yes, Corlanor (ivabradine) can cause hypotension.

Important Considerations

  • The medication is contraindicated if BP <90/50 mm Hg 1, indicating that it can exacerbate hypotension in patients with already low blood pressure.
  • Hypertension is listed as a potential adverse effect, but in the context of hypotension, this suggests that ivabradine can have variable effects on blood pressure, potentially lowering it in some cases.
  • The drug's mechanism and potential for interactions with other medications that can exacerbate bradycardia or affect blood pressure highlight the need for cautious use and monitoring.

Clinical Implications

  • Clinicians should be aware of the potential for ivabradine to cause hypotension, especially in patients with pre-existing low blood pressure or those taking other medications that can lower blood pressure.
  • Dosing adjustments and careful consideration of drug interactions are crucial when prescribing ivabradine to minimize the risk of hypotension and other adverse effects 1.

From the FDA Drug Label

The following adverse reactions have been identified in adults during post-approval use of ivabradine: syncope, hypotension, torsade de pointes, ventricular fibrillation, ventricular tachycardia, angioedema, erythema, rash, pruritus, urticaria, vertigo, and diplopia, and visual impairment.

Hypotension is listed as an adverse reaction that has been identified in adults during post-approval use of ivabradine 2 and 3. Therefore, yes, Corlanor (ivabradine) can cause hypotension.

From the Research

Effects of Corlanor (Ivabradine) on Blood Pressure

  • Ivabradine has been shown to reduce heart rate without appreciable effects on blood pressure 4.
  • A retrospective analysis of 29 consecutive patients treated for acute heart failure found that systolic blood pressure showed no variation during the first 24 hours of ivabradine administration or at discharge 5.
  • No episodes of significant bradycardia or hypotension were recorded after starting ivabradine in acute heart failure patients 5.
  • Ivabradine reduced systolic blood pressure in L-NAME-induced hypertensive rats, but its effect on blood pressure in healthy rats was not significant 6.
  • Ivabradine may help increase blood pressure in patients with heart failure by optimizing heart rate, allowing for the up-titration of beta-blockers 7, 8.

Hypotension Risk

  • There is no evidence to suggest that ivabradine causes hypotension in patients with heart failure or other conditions 4, 5, 6, 7, 8.
  • In fact, ivabradine may help improve blood pressure in patients with heart failure by increasing cardiac output and reducing heart rate 7, 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.